Europe
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Practitioners and law firms should keep their eyes peeled for the shortlists for our annual awards
Despite a broader slowdown in US IP partner hiring in 2025, litigation demand drove aggressive lateral expansion at select firms
Sponsored
Sponsored
-
Sponsored by Bugnion SpAAndrea Delbarba and Claudia Finetti of Bugnion SpA explain how supplementary protection certificates extend pharmaceutical patent protection, the role of paediatric extensions, and recent Italian clarifications on fees and regulatory processes -
Sponsored by Maiwald Intellectual PropertyKerstin Wolff of Maiwald Intellectual Property examines the EU’s winding path towards the regulation of new genomic techniques, with a proposed patent ban remaining a key source of contention
-
Sponsored by InspicosPeter Koefoed of Inspicos examines an Enlarged Board of Appeal decision on whether the internal structure of a commercially available but undisclosed product can form part of the state of the art
-
Sponsored by Gün and PartnersUğur Aktekin, Selin Bilik, and Bilge Ayperi Kemer of Gün + Partners examine a ruling confirming that trademark distinctiveness and reputation can prove bad faith under Turkish law
-
Sponsored by Maiwald Intellectual PropertySenior Maiwald lawyers outline the strategy behind the firm’s recognition as EPO Proceedings Firm of the Year at the Managing IP EMEA Awards 2025 and discuss key developments in the European intellectual property space
-
Sponsored by Bugnion SpAVieri Canepele of Bugnion SpA examines a landmark Italian Supreme Court ruling on whether a patent co-owner may exploit a jointly owned invention without consent from fellow rights holders
European Jurisdictions